---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-018903"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2022-09-27T23:59:59+00:00"
generated_at: "2026-06-23T07:12:16.088026+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Arcadia Biosciences gets Nasdaq delisting notice for bid price below $1.00

## Summary
- Nasdaq notified Arcadia on Sept 27 that common stock failed minimum $1.00 bid price for 30 consecutive days.
- Company has 180 calendar days, until March 27, 2023, to regain compliance; stock continues trading on Nasdaq Capital Market.
- To cure, closing bid price must be at least $1.00 for ten consecutive business days during the grace period.
- If not compliant by March 2023, may qualify for second 180-day period if it meets other listing standards and plans reverse stock split.
- Arcadia is monitoring bid price and may consider options, including a reverse stock split, to regain compliance.

## SEC filing metadata
- accession: 0000950170-22-018903
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2022-09-27T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017022018903/0000950170-22-018903-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017022018903/rkda-20220927.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-018903
- JSON: https://secwatch.observer/filing/0000950170-22-018903.json
- Plain text: https://secwatch.observer/filing/0000950170-22-018903.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.